In the digital age, the prevalence of infertility and the trend of delaying childbearing have significantly influenced fertility choices. Social media, particularly Instagram, has emerged as a vital part of daily life for many, with a notable percentage of American adults engaging daily. Recognizing the impact of online platforms, this cross-sectional observational study, conducted in May 2023, delved into the nature and quality of 673 Instagram posts related to infertility. It aimed to analyze the information and support available to individuals navigating infertility, particularly focusing on the posts DISCERN and Global Quality Scores (GQS) to assess their reliability and quality. The findings reveal that many women derive substantial benefits from their online experiences. Instagram serves as a source of coping mechanisms for the challenges associated with infertility diagnosis and treatment. The platform allows for the sharing of personal feelings and experiences, providing a valued sense of community and support. However, it also presents a risk of spreading misinformation, underscoring the need for careful consideration of content quality. The study emphasizes the importance of accessible and reliable online resources. It suggests that healthcare professionals should play a more active role in guiding patients to trustworthy information. In conclusion, while social media offers valuable support and unique insights for individuals dealing with infertility, the quality and reliability of the information remain critical concerns. The study advocates for a more informed and conscientious use of these platforms, highlighting the potential for both support and misinformation.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors